Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
Introduction: influenza is an acute viral disease caused by infection of the upper respiratory tract - difficult to control, which affects a large part of the population. Neuraminidase inhibitors (NAIs), such as oseltamivir and zanamivir, are the antiviral drugs utilized in Romania for the treatment...
主要な著者: | Mihai Maria Elena, Ivanciuc Alina Elena, Cherciu Carmen Maria, Mihăescu Grigore, Lazăr Mihaela |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Sciendo
2024-04-01
|
シリーズ: | Romanian Journal of Laboratory Medicine |
主題: | |
オンライン・アクセス: | https://doi.org/10.2478/rrlm-2024-0010 |
類似資料
-
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
著者:: Chiara Medaglia, 等
出版事項: (2021-06-01) -
Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
著者:: Zhichao Xu, 等
出版事項: (2022-06-01) -
Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024
著者:: Mira C. Patel, 等
出版事項: (2024-07-01) -
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea
著者:: Hwajung Yi, 等
出版事項: (2010-12-01) -
Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran
著者:: Amytis Gholami, 等
出版事項: (2022-08-01)